Risk factor
Strong & resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of AGARWALEYE.NS is 504 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomme
Buy
Sell